Generated by GPT-5-mini| PSD-95 | |
|---|---|
| Name | PSD-95 |
| Organism | Homo sapiens |
| Other names | Discs large homolog 4 |
| Length | 724 amino acids (human) |
| Family | Membrane-associated guanylate kinase (MAGUK) |
PSD-95 PSD-95 is a major postsynaptic scaffold protein highly expressed in excitatory synapses of the mammalian brain. It organizes ion channels, receptors, and signaling complexes at the postsynaptic density and contributes to synapse maturation, plasticity, and network function. PSD-95 is encoded by the DLG4 gene and belongs to the membrane-associated guanylate kinase (MAGUK) family, linking structural assembly with signaling pathways involved in neural development and disease.
PSD-95 contains modular domains that mediate protein–protein interactions: three PDZ domains (PDZ1, PDZ2, PDZ3), an SH3 domain, and a guanylate kinase-like (GK) domain. The tandem PDZ domains recognize C-terminal motifs of transmembrane proteins, while the SH3-GK tandem forms an intramolecular supramodule that stabilizes multimeric scaffold assemblies. Alternative splicing and post-translational modifications such as palmitoylation at N-terminal cysteines regulate membrane targeting and oligomerization. Structural studies using X-ray crystallography and cryo-electron microscopy have characterized PDZ–ligand recognition and the PDZ2:PDZ3 arrangement that coordinates multivalent binding.
PSD-95 concentrates and stabilizes glutamate receptors at postsynaptic sites, directly influencing excitatory neurotransmission mediated by AMPA and NMDA receptors. By anchoring NMDA receptor subunits and recruiting signaling enzymes, PSD-95 modulates calcium influx, downstream activation of kinases, and induction of synaptic plasticity phenomena such as long-term potentiation. PSD-95 scaffolds also link receptor complexes to cytoskeletal adaptors and trafficking machinery that control receptor insertion and removal during synaptic activity-dependent remodeling. Through these interactions PSD-95 influences circuit-level processes implicated in learning and memory.
PSD-95 binds a broad set of synaptic and signaling proteins via its PDZ, SH3, and GK domains. Canonical PDZ ligands include C-terminal motifs of NMDA receptor subunits and AMPA receptor auxiliary proteins. PSD-95 interacts with intracellular enzymes and adaptors including kinases, phosphatases, and small GTPase regulators that shape receptor function and spine morphology. It associates with membrane-associated proteins and transmembrane adhesion molecules that coordinate pre- and postsynaptic alignment. Multivalent interactions enable PSD-95 to serve as a hub connecting neurotransmitter receptors to intracellular signaling cascades and trafficking complexes.
During development, PSD-95 contributes to synapse formation, maturation, and stabilization by promoting clustering of postsynaptic receptors and organizing cytoskeletal linkages that determine spine shape. Activity-dependent regulation of PSD-95 levels and localization underlies developmental critical periods and experience-dependent refinement of circuits. PSD-95 abundance influences the balance between silent and functional synapses and regulates forms of synaptic plasticity across hippocampal, cortical, and striatal circuits. Temporal control of PSD-95 expression and palmitoylation state coordinates synaptic strengthening and pruning during developmental windows.
Dysregulation of PSD-95 expression, localization, or interactions has been implicated in multiple neurologic and psychiatric conditions. Altered PSD-95 levels and disrupted scaffold function have associations with seizure disorders, intellectual disability, autism spectrum disorders, and schizophrenia. Perturbations in PSD-95–dependent NMDA receptor signaling contribute to excitotoxicity and have relevance for ischemic injury and neurodegenerative processes. PSD-95 is also implicated in models of chronic pain through modulation of nociceptive synapses. Human genetic studies, patient-derived cellular models, and postmortem analyses support links between DLG4 perturbation and disease phenotypes, although causality and mechanistic specificity remain active areas of research.
Investigators employ a variety of experimental approaches to study PSD-95 function, including knockout and knockdown strategies in mouse models, overexpression and dominant-negative constructs in cultured neurons, and acute perturbation via peptides that disrupt PDZ interactions. Biochemical methods such as co-immunoprecipitation and mass spectrometry map interactomes, while super-resolution microscopy and live imaging visualize PSD-95 dynamics at nanometer scales. Electrophysiological assays in hippocampal slices and in vivo behavioral paradigms assess consequences for synaptic transmission and cognition. Complementary approaches using induced pluripotent stem cell-derived neurons and viral-mediated gene manipulation provide translational platforms to probe PSD-95 roles in human neuronal systems.
Category:Proteins